Risks of Stroke and Mortality in Atrial Fibrillation Patients Treated With Rivaroxaban and Warfarin
Stroke (1970), 2020-02, Vol.51 (2), p.549-555 [Peer Reviewed Journal]2020 American Heart Association, Inc. ;2019 Janssen Scientific Affairs. 2019 ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.119.025554 ;PMID: 31888412
Full text available